We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Medlab Middle East 2024 to Highlight Groundbreaking NextGen Medicine

By LabMedica International staff writers
Posted on 16 Jan 2024
Print article
Image: NextGen Medicine will be a key topic at the 2024 edition of Medlab Middle East (Photo courtesy of Informa Markets)
Image: NextGen Medicine will be a key topic at the 2024 edition of Medlab Middle East (Photo courtesy of Informa Markets)

Some of the most prominent researchers in the field of NextGen medicine are expected to gather at the 2024 edition of Medlab Middle East, the region’s largest medical laboratory exhibition organized by Informa Markets Healthcare (London, UK). In collaboration with Express Med Diagnostics and Research (Manama, Bahrain), Medlab Middle East will be held from 5 to 8 February. This year, Medlab Middle East will welcome more than 30,000 visitors and 900 exhibitors, with representation from 180 countries. Tracks at the event include Laboratory Management, Hematology, Quality Management, Clinical Microbiology, Histopathology, Clinical Chemistry, Clinical Genomic Interpretation, Future of the Lab, Immunology, Blood Transfusion Medicine, and Sustainability in the Lab. The Medlab Middle East Congress will return for yet another year, providing education and solutions to advance laboratory skills to over 5,000 delegates.

NextGen medicine is a cutting-edge field of healthcare that utilizes genome sequencing to create targeted healthcare strategies for specific populations and individuals for a variety of diseases and rare conditions. The 'genome' is defined as the complete set of DNA instructions in a cell, which holds all the information required for the development and functioning of an individual. In 2003, the Human Genome Project successfully developed the first complete sequence of the human genome, leading to one of the most transformative breakthroughs in science and healthcare. Genome projects targeting specific national populations are currently underway in various regions across the Middle East. Interestingly, researchers are observing differences in DNA even within those national populations.

For instance, in Oman, researchers have found that individuals native to Salalah possess a completely distinct pool of mutations in comparison to people with ancestry from Muscat or Musandam. In March 2023, the UAE launched a 10-year National Genome Strategy to aid the development and implementation of genomic research projects and improve public health priorities in the UAE. The project focuses on accelerating developments in personalized medicine and combating chronic and genetic diseases. The Emirati Genome Program, the founding project of the UAE’s National Genome Strategy, will use cutting-edge DNA sequencing and artificial intelligence to examine the genetic profile of Emiratis.

“There are three key components of NextGen medicine – prevention, early detection, and the development of targeted treatments. The future of medicine is all about moving away from a 'one size fits all' approach to more personalized health strategies. It is essential that screening strategies are adjusted to the local reality as this will ultimately save lives, improve health outcomes, and reduce the costs associated with ineffective treatments,” said Dr. Karolina Kobus, Head of Genomics and Precision Medicine Lab Technology and Innovation Advisor at Express Med Diagnostics and Research. “Genomic inheritance is unique for every population and this means that disease patterns will differ in a Caucasian individual compared with those native to the Middle East for example. While significant progress has been made in genome projects in the Western world, we must acknowledge that the current human genome that is widely referenced is mainly based on data from Caucasian individuals.”

“The Middle East genome projects have the potential to contribute significantly to global science and improve healthcare in the region. This field of study is extremely promising, and the findings could lead to major advancements in the treatment of various illnesses, such as diabetes, heart disease, and cancer,” added Tom Coleman, Group Exhibition Director, Informa Markets Healthcare. “Medlab’s partnership with Express Med Diagnostics and Research at Medlab Middle East will showcase the latest advancements in medical technology precision diagnostics and medical laboratory solutions. Chaired by Dr. Karolina Kobus, the NextGen Medicine Conference will bring together top industry experts, researchers, and healthcare professionals who are driving innovations forward. The conference will share the latest updates on regional genome projects and delve into pressing topics such as early cancer detection, precision oncology, preventative health screening, and longevity.”

New
Gold Member
Syphilis Screening Test
VDRL Antigen MR
Gold Member
C-Reactive Protein Reagent
CRP Ultra Wide Range Reagent Kit
New
H. pylori Test
STANDARD Q H. pylori Ab Test
New
STI Test
cobas TV/MG

Print article

Channels

Molecular Diagnostics

view channel
Image: The lateral flow test could detect prostate cancer more quickly and with greater accuracy (Photo courtesy of Valley Diagnostics)

Groundbreaking Test Could Detect Prostate Cancer Within Minutes Via Urine Sample

In the UK, over 52,000 men are diagnosed with prostate cancer annually, with up to one-quarter of these cases identified at a later stage, requiring more intensive treatments. The cost to the NHS for these... Read more

Hematology

view channel
Image: The new test could improve specialist transplant and transfusion practice as well as blood banking (Photo courtesy of NHS Blood and Transplant)

New Test Assesses Oxygen Delivering Ability of Red Blood Cells by Measuring Their Shape

The release of oxygen by red blood cells is a critical process for oxygenating the body's tissues, including organs and muscles, particularly in individuals receiving large blood transfusions.... Read more

Immunology

view channel
Image: Concept for the device. Memory B cells able to bind influenza virus remain stuck to channels despite shear forces (Photo courtesy of Steven George/UC Davis)

Microfluidic Chip-Based Device to Measure Viral Immunity

Each winter, a new variant of influenza emerges, posing a challenge for immunity. People who have previously been infected or vaccinated against the flu may have some level of protection, but how well... Read more

Microbiology

view channel
Image: The iFAST reader scans 5000 individual bacteria with each sample analyzed in less than a minute (Photo courtesy of iFAST)

High-Throughput AST System Uses Microchip Technology to Rapidly Analyze Bacterial Samples

Bacteria are becoming increasingly resistant to antibiotics, with resistance levels ranging from 20% to 98%, and these levels are unpredictable. Currently, antimicrobial susceptibility testing (AST) takes... Read more

Technology

view channel
Image: Human tear film protein sampling methods (Photo courtesy of Clinical Proteomics. 2024 Mar 13;21:23. doi: 10.1186/s12014-024-09475-8)

New Lens Method Analyzes Tears for Early Disease Detection

Bodily fluids, including tears and saliva, carry proteins that are released from different parts of the body. The presence of specific proteins in these biofluids can be a sign of health issues.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.